​
​

Addex Therapeutics Ownership | Who Owns Addex Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Addex Therapeutics Ownership Summary

Addex Therapeutics is owned by 6.21% institutional investors, and 93.79% retail investors.

ADXN Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAddex Therapeutics6.21%-93.79%
SectorHealthcare Stocks 47.31%8.01%44.69%
IndustryBiotech Stocks 45.43%7.81%46.75%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2023566.67%746,85561.09%630.10%350.00%1-
Jun 30, 20233-57.14%463,613-92.19%40.13%2-60.00%1-50.00%
Mar 31, 20237-5,939,200367.32%5820.43%5-2-
Dec 31, 20227-22.22%1,270,898-79.24%160.29%5-28.57%2100.00%
Sep 30, 2022980.00%6,122,606377.00%7618.20%7133.33%1-

Top Mutual Funds Shareholders

HolderShares% HoldingChange

Recent Insider Transactions

DateNameRoleActivityValue

Insider Transactions Trends

DateBuySell

ADXN Ownership FAQ

Who Owns Addex Therapeutics?

Addex Therapeutics shareholders are primarily institutional investors at 6.21%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Addex Therapeutics's industry, Biotech Stocks , is 45.43%, which Addex Therapeutics falls below.

Does Blackrock own Addex Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Addex Therapeutics.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools